ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LIPO Lipella Pharmaceuticals Inc

0.695
-0.04235 (-5.74%)
After Hours
Last Updated: 19:06:25
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Lipella Pharmaceuticals Inc LIPO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.04235 -5.74% 0.695 19:06:25
Open Price Low Price High Price Close Price Prev Close
0.7337 0.6907 0.7337 0.695 0.737351
more quote information »

Recent News

Date Time Source Heading
4/05/202408:00GLOBELipella Pharmaceuticals to Publish Abstract Detailing..
4/03/202408:00GLOBELipella Pharmaceuticals Announces FDA Type C Meeting for..
3/07/202415:23GLOBEPRISM MarketView Spotlights Lipella Pharmaceuticals as it..
3/06/202417:05EDGAR2Form SC 13D/A - General statement of acquisition of..
3/06/202417:03EDGAR2Form SC 13D/A - General statement of acquisition of..
3/05/202408:00GLOBELipella Pharmaceuticals Announces FDA Clearance of IND for..
2/27/202417:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2/27/202416:51EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/20/202408:00GLOBELipella Pharmaceuticals to Present at PropThink Digital..
2/09/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
2/07/202417:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/01/202416:09EDGAR2Form S-3 - Registration statement under Securities Act of..
1/25/202416:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/03/202416:59EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/20/202308:00GLOBELipella Pharmaceuticals Marks Successful First Year with..
11/28/202317:28EDGAR2Form 8-K - Current report
11/22/202316:05EDGAR2Form 8-K - Current report
11/14/202306:22EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/14/202306:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/10/202308:00PRNUSFDA Grants Orphan Designation for Lipella's LP-310 Drug..
11/09/202316:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/01/202316:06EDGAR2Form S-1 - General form for registration of securities under..
10/25/202316:05PRNUSLipella Pharmaceuticals Announces Closing of $2 Million..
10/24/202308:00PRNUSLipella Pharmaceuticals Announces $2 Million Private..
10/20/202308:00PRNUSLipella Pharmaceuticals Announces FDA Clearance of IND for..
10/10/202316:05EDGAR2Form DEF 14A - Other definitive proxy statements
9/21/202308:30PRNUSLipella Pharmaceuticals' Phase 2a Clinical Study Results..
9/11/202307:38EDGAR2Form 8-K - Current report
8/14/202316:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/14/202316:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202316:30EDGAR2Form 8-K - Current report
8/02/202316:05EDGAR2Form 8-K - Current report
5/15/202309:17PRNUSLipella Pharmaceuticals Reports First Quarter 2023 Financial..
5/01/202308:30PRNUSLipella Pharmaceuticals Delivers Late-Breaking Presentation..
4/17/202308:30PRNUSLipella Pharmaceuticals Enters Manufacturing Collaboration..

Your Recent History

Delayed Upgrade Clock